| Style | Citing Format |
|---|---|
| MLA | Kalincik T, et al.. "Effect of Disease-Modifying Therapy on Disability in Relapsing-Remitting Multiple Sclerosis Over 15 Years." Neurology, vol. 96, no. 5, 2021, pp. E783-E797. |
| APA | Kalincik T, Diouf I, Sharmin S, Malpas C, Spelman T, Horakova D, Havrdova EK, Trojano M, Izquierdo G, Lugaresi A, Prat A, Girard M, Duquette P, Grammond P, Jokubaitis V, Van Der Walt A, Grandmaison F, Sola P, Ferraro D, ... Butzkueven H (2021). Effect of Disease-Modifying Therapy on Disability in Relapsing-Remitting Multiple Sclerosis Over 15 Years. Neurology, 96(5), E783-E797. |
| Chicago | Kalincik T, Diouf I, Sharmin S, Malpas C, Spelman T, Horakova D, Havrdova EK, et al.. "Effect of Disease-Modifying Therapy on Disability in Relapsing-Remitting Multiple Sclerosis Over 15 Years." Neurology 96, no. 5 (2021): E783-E797. |
| Harvard | Kalincik T et al. (2021) 'Effect of Disease-Modifying Therapy on Disability in Relapsing-Remitting Multiple Sclerosis Over 15 Years', Neurology, 96(5), pp. E783-E797. |
| Vancouver | Kalincik T, Diouf I, Sharmin S, Malpas C, Spelman T, Horakova D, et al.. Effect of Disease-Modifying Therapy on Disability in Relapsing-Remitting Multiple Sclerosis Over 15 Years. Neurology. 2021;96(5):E783-E797. |
| BibTex | @article{ author = {Kalincik T and Diouf I and Sharmin S and Malpas C and Spelman T and Horakova D and Havrdova EK and Trojano M and Izquierdo G and Lugaresi A and Prat A and Girard M and Duquette P and Grammond P and Jokubaitis V and Van Der Walt A and Grandmaison F and Sola P and Ferraro D and Shaygannejad V and Alroughani R and Hupperts R and Terzi M and Boz C and Lechnerscott J and Pucci E and Van Pesch V and Granella F and Bergamaschi R and Spitaleri D and Slee M and Vucic S and Ampapa R and Mccombe P and Ramotello C and Prevost J and Olascoaga J and Cristiano E and Barnett M and Saladino ML and Sanchezmenoyo JL and Hodgkinson S and Rozsa C and Hughes S and Moore F and Shaw C and Butler E and Skibina O and Gray O and Kermode A and Csepany T and Singhal B and Shuey N and Piroska I and Taylor B and Simo M and Sirbu CA and Sas A and Butzkueven H}, title = {Effect of Disease-Modifying Therapy on Disability in Relapsing-Remitting Multiple Sclerosis Over 15 Years}, journal = {Neurology}, volume = {96}, number = {5}, pages = {E783-E797}, year = {2021} } |
| RIS | TY - JOUR AU - Kalincik T AU - Diouf I AU - Sharmin S AU - Malpas C AU - Spelman T AU - Horakova D AU - Havrdova EK AU - Trojano M AU - Izquierdo G AU - Lugaresi A AU - Prat A AU - Girard M AU - Duquette P AU - Grammond P AU - Jokubaitis V AU - Van Der Walt A AU - Grandmaison F AU - Sola P AU - Ferraro D AU - Shaygannejad V AU - Alroughani R AU - Hupperts R AU - Terzi M AU - Boz C AU - Lechnerscott J AU - Pucci E AU - Van Pesch V AU - Granella F AU - Bergamaschi R AU - Spitaleri D AU - Slee M AU - Vucic S AU - Ampapa R AU - Mccombe P AU - Ramotello C AU - Prevost J AU - Olascoaga J AU - Cristiano E AU - Barnett M AU - Saladino ML AU - Sanchezmenoyo JL AU - Hodgkinson S AU - Rozsa C AU - Hughes S AU - Moore F AU - Shaw C AU - Butler E AU - Skibina O AU - Gray O AU - Kermode A AU - Csepany T AU - Singhal B AU - Shuey N AU - Piroska I AU - Taylor B AU - Simo M AU - Sirbu CA AU - Sas A AU - Butzkueven H TI - Effect of Disease-Modifying Therapy on Disability in Relapsing-Remitting Multiple Sclerosis Over 15 Years JO - Neurology VL - 96 IS - 5 SP - E783 EP - E797 PY - 2021 ER - |